Schiller has launched CARDIOVIT® FT-2 to meet hospital demands. Schiller focused on the benefits in the hospital: The new ECG device is highly hygienic. The seamless...
Inspire Medical Systems, Inc. reported financial results for the quarter and year ended December 31, 2023. “We are thrilled with our strong performance in the fourth...
Bruker Corporation announced that it has acquired Spectral Instruments Imaging LLC. This acquisition fills a gap in the technology and product portfolio of the Bruker BioSpin...
Edwards Lifesciences reported financial results for the quarter ended December 31, 2023. Highlights and outlook Q4 sales grew 14 percent to $1.53 billion; constant currency sales...
GE HealthCare reported financial results for the fourth quarter ended December 31, 2023. GE HealthCare President and CEO Peter Arduini said, “After our first year as...
Veracyte, Inc. announced it has completed its acquisition of C2i Genomics, Inc., adding whole-genome minimal residual disease (MRD) capabilities to its novel diagnostics platform and expanding...
Varex Imaging Corporation announced its unaudited financial results for the first quarter of fiscal year 2024. 1QFY24 Summary Revenues $190 million GAAP gross margin 30% |...
Evaxion Biotech A/S announced the closing on February 5, 2024 of its previously announced public offering of 3,750,000 of its American Depositary Shares and warrants to...
NexImmune, Inc. announced the closing of its previously announced registered direct offering of 304,731 shares of its common stock at a purchase price of $12.05 per...
Procyrion™, Inc. announced the completion of a $57.7 million Series E funding round, including the conversion of $10.0 million of interim financing. These funds will be...
Vektor Medical announced a $16 million Series A investment co-led by Solas BioVentures and TVM Capital Life Science. This funding underscores investor confidence in Vektor’s vision...
Revelation Biosciences Inc. announced the closing on February 5, 2024 of its previously announced public offering of 128,470 shares of its common stock and 1,236,530 pre-funded...
The Cigna Group announced that it has commenced tender offers to purchase for cash any and all of The Cigna Group’s 3.50% Senior Notes due 2024...
Adverum Biotechnologies, Inc. announced that it has agreed to sell approximately 106.25 million shares of its common stock to a select group of institutional and accredited...
Mesa Laboratories, Inc. announced results for its third fiscal quarter ended December 31, 2023. Third quarter FY 2024 compared to third quarter FY 2023: Revenues decreased...
Copyright © 2024 Medical Buyer